Establishment Labs Holdings Inc.
Health
Performance
6.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Establishment Labs Holdings Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

21.07.2026
Picking up speed. Momentum turning positive.
19.07.2026
Trouble brewing. Volatility and pressure rising.
15.07.2026
Barely upright. Still chaotic, but slowly finding some balance.
01.01.2026
Danger zone. Balance sheet’s flashing red across the board.
ESTA
Establishment Labs Holdings Inc.
96.31
+3.09%
6.1
Sell
Buy
Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Establishment Labs Holdings Inc. do? Business model and key facts

Get the full picture of Establishment Labs Holdings Inc.: what it builds, where it operates, and how it makes money.

Establishment Labs Holdings Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 1004

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.

shop
Company facts
Fillipo Peter Caldini
CEO
1004
Employees worldwide
shop
Performance
119.3%
Last 12 months
27.97%
Last 5 years
shop
Growth
$211.08M
Revenue year
$-51,064,000
Net income
shop
Valuation
$2.72B
Market Cap
-42.37
Price/Earnings Ratio

Stocks related to Establishment Labs Holdings Inc.

Selected based on industry alignment and relative market positioning.

ITGR
Integer Holdings Corporation
95.41
-0.71%
5.3
Sell
Buy
Integer Holdings Corporation
IRTC
iRhythm Technologies, Inc.
109.44
-1.73%
5.6
Sell
Buy
iRhythm Technologies, Inc.
LIVN
LivaNova PLC
79.52
+0.39%
3.8
Sell
Buy
LivaNova PLC
TMDX
TransMedics Group, Inc.
74.67
+1.63%
8.8
Sell
Buy
TransMedics Group, Inc.
AXGN
AxoGen, Inc.
40.13
+1.65%
5.9
Sell
Buy
AxoGen, Inc.

Events and news impacting Establishment Labs Holdings Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Establishment Labs Holdings Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.